Log in using OpenID

Clostridium Vaccine Market

Clostridium Vaccine Market - Size, Share,
Growth, Outlook, and Opportunity Analysis,
Clostridium difficile infections are the most widely recognized cause of hospital acquired infectious
diarrhea. There is a critical need for development of prevention vaccine for this disease. Clostridium
difficile, is a gram-positive bacterium, which produces an anaerobic toxin that is transmitted through
fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due
to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to
watery diarrhea or serious intestinal condition such as colitis and colonic perforation.
Request Sample Copy of Research Report:
Growing C. difficile infections at healthcare facilities and antibiotic resistance to treatment drugs are
propelling demand for development of prophylactic options to reduce the risk of infection in vulnerable
patients. A 2013 bulletin published from the Centers for Disease Control and Prevention (CDC)
outlined Clostridium difficile as urgent antibiotic-resistance threats in the U.S.
Clostridium Vaccine Market Drivers
Rising incidence and high prevalence of clostridium difficile infection is expected to boost growth
of the market over the forecast period. Incidence of clostridium difficile infection has been
witnessing an increase since the recent past, due to its infection recurrence and antibiotic
resistance. According to Centers for Disease Control and Prevention (CDC), in 2015 around half a
million people in the U.S. suffer from clostridium difficile infection in a year.
Moreover, according to National Center for Biotechnology Information (NCBI), an estimated
37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review
and meta-analysis of studies published in National Center for Biotechnology Information (NCBI),
2016, conducted in China between 2010 and 2016, reported significant incidence of clostridium
difficile infection in China.
Report includes chapters which deeply display the following deliverable about industry :
• Clostridium Vaccine Market Research Objective and Assumption
• Clostridium Vaccine Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Clostridium Vaccine Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value
Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Clostridium Vaccine Market, By Regions
• Clostridium Vaccine Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Clostridium Vaccine Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Clostridium Vaccine Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Clostridium Vaccine Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Clostridium Vaccine Market Key Players
Key players operating in global clostridium vaccine market include Valneva SE and
Pfizer, Inc.
Inquire Here Before Purchase:
Clostridium Vaccine Market Taxonomy:
The global clostridium vaccine market is segmented on the basis of vaccine and region
By Vaccine
• PF-06425090
• VLA84
By Region
North America
Latin America
Asia Pacific
Middle East
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Rushikesh76   documents Email
Health and Medicine
File Size
159 KB
Report inappropriate content